Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Columbia Laboratories, Inc.
Data From Meta-Analysis Show Clinical Pregnancy Rate With Vaginal Progesterone is Comparable With Intramuscular Progesterone When Administered at Optimal Dosing in Infertility Patients
May 25th, 2009
Columbia Laboratories, Inc. (Nasdaq:CBRX) announced that the full report of a meta-analysis evaluating vaginally-administered progesterone versus intramuscular (IM) progesterone injections in infertility patients is available online. CRINONE® 8% was the vaginal treatment used in five out of the seven studies analyzed. Key findings of the meta-analysis show that the clinical pregnancy rate with vaginal progesterone is comparable with IM progesterone when administered at optimal dosing, and that vaginal progesterone is associated with a significantly lower rate of miscarriage than IM progesterone. The meta-analysis was initially published as an abstract and presented at the American Society...
Source: Biotech Business Week (2009-05-25)
|
|
Advertisement |
|
|
|
